about
Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodiesGlomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy.Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.Antineutrophil cytoplasmic antibodies (ANCA).Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.Immunology of membranous nephropathy: from animal models to humans.Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics.Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis.Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritisLow-dose rituximab is poorly effective in patients with primary membranous nephropathy.Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells.Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener's).The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature.Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis.Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseasesAnti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretionPrevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndromealpha1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implicationsLinee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015Il test ANA-reflexComplement cascade in systemic lupus erythematosus: analyses of the three activation pathways.Anti-C1q Autoantibodies in Lupus NephritisAre laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritisAnti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosisDiagnostic significance and antigen specificity of antineutrophil cytoplasmic antibodies in renal diseases. A prospective multicentre study. Italian Group of Renal ImmunopathologyAntibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigensLack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathyClinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseasesProperties of circulating IgA molecules in Henoch-Schönlein purpura nephritis with focus on neutrophil cytoplasmic antigen IgA binding (IgA-ANCA): new insight into a debated issue. Italian Group of Renal Immunopathology Collaborative Study on HenochRecognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significanceAnti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance
P50
Q27000411-54A3412F-B763-4FA0-B3F0-A52EE641FC53Q30596600-DBE9C0EC-33A2-42EB-87B3-C0886A892EC5Q35169740-034F7AC4-C1DA-4B0B-A935-E2CC797E7B0FQ35422370-46E024FD-FF11-4D0E-A5D8-2BE0A8129E6EQ36086150-C834DB4C-425E-4028-B772-5DF58766E50EQ36199508-A4F977A9-F7D3-456B-969B-25CBEC74C674Q38037902-C8877C55-938F-4C59-8528-FC222A51C3DCQ38605469-649C95F5-B6C6-4C9A-B956-5680D44E2991Q38623075-AD0C64FC-467D-46D8-A791-B46FB971F820Q38899125-5B570443-FFE6-497B-A236-19F89E9BB55DQ40041740-ADD9D0C6-9494-4FE2-ACDA-95DE3F1C533CQ40338767-AB914000-CAA8-4616-8378-5FA6F1AB36B9Q40446804-86C8E102-E0A4-453F-B205-C69D3D511040Q40663445-7F411FB7-8BAB-4A11-BCFF-502903F950B6Q41126709-70DD62A2-4D54-40AD-8F3B-D8EC4BD29EA8Q41197918-0E0AB2C8-9854-477A-B669-57ADBF10A86AQ43801089-9DAFE4CE-BC8C-46E1-A6FF-D54F89B9B3BDQ47439233-E43CFA53-E241-4576-AB76-089C2E777651Q48108645-899359CB-6604-4D44-B1C5-6FB469265267Q50448184-9B40AFFC-F4B7-4BE4-9E35-0C9E27971C41Q51403741-3B5F48B7-B97F-4298-AC69-79B8057174C0Q52601580-C7069596-45D6-44AD-B378-373BA8342489Q56379923-FE9A3727-59AF-46B2-816D-C2CC22BF4D19Q56943448-F45A7BAF-5DC5-49D3-9DED-6855A2902299Q58051633-C418848A-4602-43AD-8C89-859377F4BF00Q58620568-53E3E8FD-2B43-4A85-81C5-5DD642BDE128Q58985221-9A901DFD-BB53-41E1-9FFE-0A5B66476255Q58985266-62282B01-8AFB-4BBE-8FAF-7ACEF15206A2Q59130824-8794F730-F6B2-45E8-92C4-3A33AE07A3A8Q60729406-25865F8A-753B-4945-A542-66DCA824F622Q60729408-2AE41D44-5E9B-4C60-B21A-2008FD2A4BEDQ60729418-DB811313-05ED-4E53-B282-704C8EF28568Q62488206-36872D13-E51D-41A3-9E74-0D8124A7B7AFQ71647372-96DC55FC-3FE1-4CCD-B0AD-ED05047411B3Q72252865-D2C27CA4-8249-4C96-B190-21E8F174DC6EQ72712174-07E1CD93-2865-44C9-8150-BE49D7C420C8Q72881678-B73E9FEE-6F4B-4C39-8546-EC0C84BC14D9Q73932776-525EF0C6-A259-4A8E-BACC-823DE624CA84Q77942848-755F8D21-9B3A-4870-B144-7EF4FD303B22Q80367277-C7061A40-660F-44AA-990C-B1FD20993E73
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonella Radice
@ast
Antonella Radice
@en
Antonella Radice
@es
Antonella Radice
@nl
type
label
Antonella Radice
@ast
Antonella Radice
@en
Antonella Radice
@es
Antonella Radice
@nl
prefLabel
Antonella Radice
@ast
Antonella Radice
@en
Antonella Radice
@es
Antonella Radice
@nl
P106
P1153
7003673971
P21
P31
P496
0000-0002-3886-8812